# A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-988 in Healthy Participants

> **NCT04082481** · PHASE1 · WITHDRAWN · sponsor: **Takeda**

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** TAK-988
- **DRUG:** TAK-988 Placebo

## Key facts

- **NCT ID:** NCT04082481
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-11-17
- **Primary completion:** 2022-04-29
- **Final completion:** 2022-04-29
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study stopped early, before enrolling its first participant.
- **Last updated:** 2021-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04082481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04082481, "A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-988 in Healthy Participants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04082481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*